These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2971883)

  • 21. Onset of dementia is associated with age at menopause in women with Down's syndrome.
    Schupf N; Pang D; Patel BN; Silverman W; Schubert R; Lai F; Kline JK; Stern Y; Ferin M; Tycko B; Mayeux R
    Ann Neurol; 2003 Oct; 54(4):433-8. PubMed ID: 14520653
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [New physiopathological mechanisms in Alzheimer's disease and Down's syndrome].
    Salamanca-Gómez F
    Gac Med Mex; 1998; 134(2):251-2. PubMed ID: 9619004
    [No Abstract]   [Full Text] [Related]  

  • 23. Erythrocyte membrane changes of individuals with Down's syndrome in various stages of Alzheimer-type dementia.
    Bosman GJ; Visser FE; De Man AJ; Bartholomeus IG; De Grip WJ
    Neurobiol Aging; 1993; 14(3):223-8. PubMed ID: 8321389
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Discrepancy between Alzheimer-type neuropathology and dementia in persons with Down's syndrome.
    Wisniewski HM; Rabe A
    Ann N Y Acad Sci; 1986; 477():247-60. PubMed ID: 2949682
    [No Abstract]   [Full Text] [Related]  

  • 25. Detection of Alzheimer disease in individuals with Down syndrome.
    Nelson L; Lott I; Touchette P; Satz P; D'Elia L
    Am J Ment Retard; 1995 May; 99(6):616-22. PubMed ID: 7632429
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oxidative stress: a bridge between Down's syndrome and Alzheimer's disease.
    Zana M; Janka Z; Kálmán J
    Neurobiol Aging; 2007 May; 28(5):648-76. PubMed ID: 16624449
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of Abeta11-40/42 peptide deposition in Alzheimer's disease and young Down's syndrome brains: implication of N-terminally truncated Abeta species in the pathogenesis of Alzheimer's disease.
    Liu K; Solano I; Mann D; Lemere C; Mercken M; Trojanowski JQ; Lee VM
    Acta Neuropathol; 2006 Aug; 112(2):163-74. PubMed ID: 16865398
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dementia and Down syndrome.
    Tyler CV; Shank JC
    J Fam Pract; 1996 Jun; 42(6):619-21. PubMed ID: 8656174
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Soluble Abeta homeostasis in AD and DS: impairment of anti-amyloidogenic protection by lipoproteins.
    Matsubara E; Sekijima Y; Tokuda T; Urakami K; Amari M; Shizuka-Ikeda M; Tomidokoro Y; Ikeda M; Kawarabayashi T; Harigaya Y; Ikeda S; Murakami T; Abe K; Otomo E; Hirai S; Frangione B; Ghiso J; Shoji M
    Neurobiol Aging; 2004 Aug; 25(7):833-41. PubMed ID: 15212837
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Atherosclerosis, Down's syndrome, and Alzheimer's disease.
    Hughes W
    Br Med J; 1977 Sep; 2(6088):702. PubMed ID: 143302
    [No Abstract]   [Full Text] [Related]  

  • 31. Myoclonus in Down's syndrome. Association with alzheimer's disease.
    Blumbergs P; Beran R; Hicks P
    Arch Neurol; 1981 Jul; 38(7):453-4. PubMed ID: 6454406
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alzheimer-like brain monoamine deficits in adults with Down's syndrome.
    Reynolds GP; Godridge H
    Lancet; 1985 Dec; 2(8468):1368-9. PubMed ID: 2866421
    [No Abstract]   [Full Text] [Related]  

  • 33. Neurotensin immunoreactivity in post-mortem brain is increased in Down's syndrome but not in Alzheimer-type dementia.
    Yates CM; Fink G; Bennie JG; Gordon A; Simpson J; Eskay RL
    J Neurol Sci; 1985 Mar; 67(3):327-35. PubMed ID: 3157784
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Down's syndrome and Parkinson's disease.
    Brandel JP; Marconi R; Serdaru M; Vidailhet M; Agid Y
    Neurology; 1994 Dec; 44(12):2419-20. PubMed ID: 7991152
    [No Abstract]   [Full Text] [Related]  

  • 35. Man in the Mirror: Delusion of Misidentification in Down's Syndrome With Alzheimer's Disease.
    Velayudhan L; Jesu A
    J Neuropsychiatry Clin Neurosci; 2015; 27(2):e151. PubMed ID: 25923863
    [No Abstract]   [Full Text] [Related]  

  • 36. Free radical damage in Down's syndrome brain.
    Reynolds GP; Cutts AJ
    Biochem Soc Trans; 1993 May; 21(2):221S. PubMed ID: 8359470
    [No Abstract]   [Full Text] [Related]  

  • 37. Vitamin E concentrations in human brain of patients with Alzheimer's disease, fetuses with Down's syndrome, centenarians, and controls.
    Metcalfe T; Bowen DM; Muller DP
    Neurochem Res; 1989 Dec; 14(12):1209-12. PubMed ID: 2534160
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alzheimer's disease in Down's syndrome: visual retention deficits.
    Dalton AJ; Crapper DR; Schlotterer GR
    Cortex; 1974 Dec; 10(4):366-77. PubMed ID: 4281378
    [No Abstract]   [Full Text] [Related]  

  • 39. Protein variations associated with Down's syndrome, chromosome 21, and Alzheimer's disease.
    Van Keuren ML; Goldman D; Merril CR
    Ann N Y Acad Sci; 1982; 396():55-67. PubMed ID: 6217777
    [No Abstract]   [Full Text] [Related]  

  • 40. Concerns about using Zn supplementation in Down's syndrome (DS) children.
    Bucci I; Napolitano G; Giuliani C; Lio S; Minnucci A; Monaco F; Di Giacomo F; Calabrese G; Palka G; Sabatino G
    Biol Trace Elem Res; 2001; 82(1-3):273-5. PubMed ID: 11697775
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.